BTG3 and systemic lupus erythematosus: Accurate differential can be achieved by detailing ocular presentation and eliminating possible masqueraders with SLE-specific antibodies (ANA, anti-dsDNA, and anti-sm antibodies), complement panel levels, and anti-beta 2 glycoprotein 1 antibodies [66].